Biohaven Quick Ratio 2016-2023 | BHVN
Historical quick ratio values for Biohaven (BHVN) over the last 10 years.
| Biohaven Quick Ratio Historical Data |
| Date |
Current Assets - Inventory |
Current Liabilities |
Quick Ratio |
| 2023-03-31 |
$0.00B |
$0.11B |
0.00 |
| 2022-12-31 |
$0.00B |
$0.09B |
0.00 |
| 2022-09-30 |
$0.00B |
$0.03B |
0.00 |
| 2022-06-30 |
$1.07B |
$0.67B |
1.59 |
| 2022-03-31 |
$1.08B |
$0.58B |
1.87 |
| 2021-12-31 |
$0.00B |
$0.04B |
0.00 |
| 2021-09-30 |
$0.87B |
$0.46B |
1.88 |
| 2021-06-30 |
$0.60B |
$0.40B |
1.51 |
| 2021-03-31 |
$0.84B |
$0.40B |
2.13 |
| 2020-12-31 |
$0.56B |
$0.28B |
2.03 |
| 2020-09-30 |
$0.69B |
$0.22B |
3.17 |
| 2020-06-30 |
$0.35B |
$0.17B |
2.13 |
| 2020-03-31 |
$0.47B |
$0.12B |
3.85 |
| 2019-12-31 |
$0.00B |
|
0.00 |
| 2019-09-30 |
$0.00B |
$0.05B |
0.00 |
| 2019-06-30 |
$0.00B |
$0.05B |
0.00 |
| 2019-03-31 |
$0.00B |
$0.02B |
0.00 |
| 2018-12-31 |
$0.00B |
$0.02B |
0.00 |
| 2018-09-30 |
$0.00B |
$0.02B |
0.00 |
| 2018-06-30 |
$0.00B |
$0.01B |
0.00 |
| 2018-03-31 |
$0.00B |
$0.02B |
0.00 |
| 2017-12-31 |
$0.00B |
$0.01B |
0.00 |
| 2017-09-30 |
$0.00B |
$0.02B |
0.00 |
| 2017-06-30 |
$0.00B |
$0.02B |
0.00 |
| 2017-03-31 |
$0.00B |
$0.02B |
0.00 |
| 2016-12-31 |
$0.00B |
$0.01B |
0.00 |
| 2016-09-30 |
$0.00B |
|
0.00 |
| 2016-06-30 |
$0.00B |
|
0.00 |
| 2016-03-31 |
$0.00B |
|
0.00 |
| 2015-12-31 |
$0.00B |
$0.00B |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$1.059B |
$0.463B |
|
Biohaven Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases principally in the United States. Biohaven Ltd., formerly known as BIOHAVEN PHARM, is based in New Haven, Connecticut.
|
